Replies to post #225386 on Biotech Values

[Bickema]

ABBV punished, down 15%, overreaction here Dew?

[DewDiligence]

Vantage values AGN’s Botox franchise at $46.1B (scan down):

https://www.evaluate.com/vantage/articles/data-insights/other-data/abbvergan-numbers